학술논문
Safety and Efficacy of Twice-Weekly Versus Once-Weekly Infliximab for Refractory Acute Graft-Versus-Host Disease in Pediatric Patients
Document Type
Abstract
Source
In Biology of Blood and Marrow Transplantation March 2020 26(3) Supplement:S391-S391
Subject
Language
ISSN
1083-8791